指南与共识妇产影像介入US

经宫颈超声引导射频消融治疗症状性子宫肌瘤的意义:德语国家专家共识

The significance of transcervical ultrasound-guided radiofrequency ablation in the treatment of symptomatic fibroids: results of an expert consensus from German-speaking countries.
指南 / 共识 · Arch Gynecol Obstet · 2022-01-01

子宫肌瘤是女性常见疾病,主要引起出血异常和下腹痛,并降低生育机会。经宫颈超声引导射频消融(TRFA)自2013年起在德国使用,后在德语国家推广,德国、奥地利和瑞士已完成超过1200例治疗。来自这三国的专家召开共识会议,分析该技术在症状性子宫肌瘤整体治疗中的意义。

要点

  • TRFA是一种新型保留器官的微创治疗症状性子宫肌瘤的方法。
  • TRFA自2013年起在德国使用,德国、奥地利和瑞士已完成超过1200例治疗。
  • 专家共识会议旨在分析TRFA在症状性子宫肌瘤整体治疗中的意义。

核心结论

  • 专家共识会议分析了TRFA在症状性子宫肌瘤整体治疗中的意义。

研究设计与样本

  • 德语国家(德国、奥地利、瑞士)专家共识会议,基于三国已完成的超过1200例TRFA治疗经验进行分析。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Uterine fibroids are one of the most common diseases in female patients, lead mainly to bleeding disorders and lower abdominal pain, and reduce the chance of having children. In recent years we have seen a trend towards more and more pharmacotherapies and minimally invasive organ-preserving treatments. One novel and innovative procedure for an organ-preserving treatment of symptomatic uterine fibroids is the transcervical ultrasound-guided radiofrequency ablation (TRFA). TRFA has been used in Germany since 2013 and later found use in other German-speaking countries as well. There have now been more than 1200 TRFA treatments performed in Germany, Austria, and Switzerland. Experts from these three countries came together for a consensus meeting to analyze the significance of the procedure in the overall concept of the treatment of symptomatic uterine fibroids.

来源:Arch Gynecol Obstet,查看原文。版权归原作者所有。

引用

  1. Römer T, Bends R, Christoffel L, et al. The significance of transcervical ultrasound-guided radiofrequency ablation in the treatment of symptomatic fibroids: results of an expert consensus from German-speaking countries. Arch Gynecol Obstet. 2022. PMID: 35316395. doi:10.1007/s00404-022-06516-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。